BioLineRx Ltd. ( BLRX) - Key Metrics
BLRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.07 | -$0.69 | -$0.73 | -$0.73 |
| 2026Q1 | $0.11 | -$0.58 | -$0.51 | -$0.52 |
| 2025Q4 | $0.04 | -$0.32 | -$0.74 | -$0.75 |
| 2025Q3 | $0.11 | -$0.25 | -$0.53 | -$0.53 |
| 2025Q2 | $0.08 | -$1 | -$0.04 | -$0.04 |
BLRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.11 |
| 2026Q1 | 0% | -0.99 |
| 2025Q4 | 0% | -2.17 |
| 2025Q3 | 0% | -4.29 |
| 2025Q2 | 0% | -1.15 |
BLRX
Price: $2.17
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 323100
Ebitda: -7.1 millionMarket Capitalization: 10.3 million